Premium
Forte Biosciences Inc (FBRX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It pl... Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.3949 | -3.10700236035 | 12.71 | 14.49 | 12.2 | 50297 | 13.51823673 | CS |
| 4 | 0.0851 | 0.69582992641 | 12.23 | 19.63 | 10.15 | 196042 | 11.75536116 | CS |
| 12 | 6.0351 | 96.1003184713 | 6.28 | 19.63 | 4.9 | 96163 | 10.95809656 | CS |
| 26 | -7.2049 | -36.9103483607 | 19.52 | 20.5 | 4.9 | 64833 | 10.76854739 | CS |
| 52 | -1.1599 | -8.60779220779 | 13.475 | 28.68 | 4.11 | 185362 | 13.08113825 | CS |
| 156 | -24.9349 | -66.9393288591 | 37.25 | 38.5 | 4.11 | 105975 | 18.38029835 | CS |
| 260 | -361.6849 | -96.7071925134 | 374 | 1349.75 | 4.11 | 241955 | 191.07195612 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
